Revolutionize Data Analysis: Embrace Median Metrics for Clearer Insights

 

In the latest episode of Benchmarks Symposium, hosted by Vodori, Annalise Ludtke, the Senior Manager of Marketing and Communications at Vodori, and Jesse Horrell, the VP of Customer Success, embark on an in-depth discussion about the pivotal role of median metrics in enhancing the quality of data analysis presented in Vodori’s 2023 Benchmarks Report. Their conversation delves into the strategic inclusion of median values alongside means to provide a clearer, more accurate picture of process benchmarks, effectively mitigating the distortion caused by outliers. This methodological refinement is a testament to Vodori’s dedication to offering organizations a more precise tool for evaluating their performance, pinpointing strengths, and identifying areas ripe for development.

Ludtke and Horrell further illustrate how these statistical measures—especially the newly introduced median metrics—can significantly impact an organization’s ability to comprehend and improve its operational processes. By analyzing key metrics such as job and review durations and highlighting the complementary nature of means and medians, they shed light on the critical insights these numbers can unveil about process efficiencies and challenges. This episode of Benchmarks Symposium not only highlights the criticality of adopting a nuanced approach to data analysis but also positions Vodori’s 2023 Benchmarks Report as an essential resource for businesses intent on leveraging detailed insights for strategic planning, thereby facilitating a pathway towards sustained process improvement and optimization.

Recent Episodes

Generative AI has captured the public imagination, but its most transformative use cases may lie far from flashy consumer tools. In healthcare operations, where complexity, inefficiency, and fragmentation remain persistent challenges, AI is now driving measurable improvements. Research suggests AI-enabled healthcare systems could cut administrative costs by up to $360 billion in the U.S. alone….

Corganics is redefining standards in clinical cannabinoid care with THC-free, medical-grade CBD products developed for use exclusively by healthcare professionals. Backed by Advanced Lipid Technology, FDA-registered manufacturing, and rigorous third-party testing, Corganics offers a level of trust and transparency rare in the CBD space. In a conversation with Reggie Gatewood, President of Corganics, Brooke Williams,…

Corganics’ Clinical CBD Drops—THC-free, medical-grade, and developed with Advanced Lipid Technology—are designed for healthcare professionals seeking a trusted, science-backed cannabinoid solution for their patients. Manufactured in an FDA-registered facility and third-party lab-tested, these drops are a cornerstone of Corganics’ clinical approach. At Beautiphi Aesthetic Boutique, founder Kelly Hermans, CRNA, has integrated the drops into patient…